Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Policies

Healthcare on the cusp of big leap

By LIU ZHIHUA | China Daily | Updated: 2020-12-07 07:39
Share
Share - WeChat
Staff members inspect equipment at a production workshop of Novo Nordisk (China) Pharmaceuticals on Feb 25. The parent company will invest $30.5 million to set up a new unit at the Lingang Special Area of the China (Shanghai) Pilot Free Trade Zone. [Photo/Xinhua]

China's economic resilience, policy supports, long-term strategy attract big-ticket investments

Tailwinds are not only offsetting the negative economic impact of COVID-19 on China's healthcare industry but also speeding up its evolution, heralding restructuring, expansion and rise in foreign investment flows, industry insiders said.

The glad tidings promise to make health one of society's top priorities as the nation swears by the new dual-circulation pattern for high-quality development in the post-pandemic era.

A confluence of several factors-growing demand for higher-quality healthcare, improved protection for intellectual property rights, deepening of China's reform and opening-up, reinforced commitment to globalization, a business-friendly environment, integration of cutting-edge technologies into the medical field, new agreements for regional trade and economic cooperation, and a long-term national health strategy-h(huán)as created a near-perfect setting for the next big leap of the healthcare industry, they said.

To be sure, COVID-19 has caused massive job losses and a sharp fall in global foreign direct investment flows, but a quicker-than-expected economic recovery and remarkable resilience have made China one of the most attractive investment destinations in the global healthcare industry.

For instance, during the third China International Import Expo in early November in Shanghai, Novo Nordisk, a global healthcare leader in diabetes treatment, announced it will invest 200 million yuan ($30.5 million) to establish a new facility at the Lingang Special Area of the China (Shanghai) Pilot Free Trade Zone.

Novo Nordisk's new unit will foray into several market segments, including marketing, pharmaceutical research and development, and finished goods imports and distribution.

"The excellent business environment and preferential policy support in the Lingang Special Area will allow this new entity to become a powerful driver of Novo Nordisk's strategy of solidifying its value chain in China," the company said in a statement.

1 2 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 国产精品久久99| 精品久久久无码人妻中文字幕豆芽| 日本天堂视频在线观看| 午夜福利AV无码一区二区| 1000部精品久久久久久久久| 日韩在线一区二区三区视频| 人妻av无码专区| 达达兔欧美午夜国产亚洲| 娇小枯瘦日本xxxx| 亚洲日本香蕉视频观看视频| 老头猛挺进小莹的体内小说全集| 天天av天天av天天透| 久久国产精品波多野结衣AV | 久久精品亚洲一区二区三区浴池| 波多野结衣1区| 国产日韩在线观看视频网站| 中文综合在线观| 狠狠97人人婷婷五月| 国产亚洲视频在线播放大全| 3p视频在线观看| 女人18毛片a级毛片| 亚洲中文字幕久久精品无码a| 色哟哟www网站| 国产精品www| 99国产精品国产精品九九| 成人欧美一区二区三区视频| 久精品国产欧美亚洲色aⅴ大片| 老司机午夜精品视频播放| 国产欧美另类久久久精品免费| 中文字幕日本一区| 污网站在线观看视频| 君子温如玉po| 高清一区二区三区视频| 国产精品久久久久久| 99久久精品费精品国产| 尤物yw午夜国产精品视频| 久久久国产精华液| 波多野吉衣AV无码| 午夜人妻久久久久久久久| 西西午夜无码大胆啪啪国模| 国产欧美一区二区三区在线看|